wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47325431-9DC3416E-DFE9-482B-BDA5-9AEE2AAC6161
Q47325431-9DC3416E-DFE9-482B-BDA5-9AEE2AAC6161
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47325431-9DC3416E-DFE9-482B-BDA5-9AEE2AAC6161
Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.
P2860
Q47325431-9DC3416E-DFE9-482B-BDA5-9AEE2AAC6161
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47325431-9DC3416E-DFE9-482B-BDA5-9AEE2AAC6161
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
361233f755830835cc6b5b4397e44510d73262f6
P2860
Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD2 antibody ch14.18/CHO show higher ADCC levels and improved event-free survival.